Iaterion Inc biotechnology company defining itself as designing innovative and novel therapeutics to improve overall health and wellness. eecent developments at Iaterion include cancer, immune modulation, antivirals and nuclear receptor modulation. Responding to the global call for COVID-19 pandemic solution - an urgent need for a safe and effective treatment to combat coronaviruses, prevent transmission via asymptomatic individuals, and to halt severe progression in early infected individuals - Iaterion management indicate the firm as having identified a combination of antiviral compounds and immune modulating compounds which suggest the opossbility of applicability not only to the current pandemic, but also to future, novel strains. Further, manageent suggest that Iaterionâs AVIM1 compound can halt the emergence of a future pandemic wave. Management indicate that early in the Covid outbreak, Iaterion had identified multiple antiviral compounds that neutralize SARS-CoV-2, SARS and MERS at very high potency and selectivity. Iaterionâs leads are 50-100 times more potent than Remdesivi